Project Grant R21AG084231
- This federal Project Grant award, funded by the National Institute on Aging (CFDA 93.866 Aging Research), aims to investigate the neural mechanisms underlying locomotor adaptation deficits and freezing of gait (FOG) in Parkinson's disease (PD). The $405,045 grant, awarded to the University of Florida, will utilize novel deep brain stimulation (DBS) technology with recording capabilities to study neural activity in the globus pallidus internus (GPI) during treadmill walking in 60 PD patients,...
- This Project Grant award from the National Institute on Aging (NIA), funded under the Aging Research program (CFDA 93.866), will support research to understand the pathophysiological changes associated with the dual decline in gait and cognition in older adults. The $242,489 award to Vanderbilt University Medical Center will leverage the Vanderbilt Memory and Aging Project cohort to conduct both cross-sectional and longitudinal proteomic analysis to identify the unique plasma proteome signatures...
- This Project Grant award of $353,391.00, provided by the National Institute on Aging (CFDA 93.866 - Aging Research), aims to validate the use of a "Personal Learning Curve" paradigm as a sensitive marker of early memory decline related to Alzheimer's disease (AD) biomarkers in a large, diverse sample of older adults. The study seeks to determine if this digital cognitive assessment tool, which measures learning over repeated evaluations, can detect subtle AD-related memory failures...
- This Project Grant award of $114,498 from the National Institute on Aging (CFDA 93.866 - Aging Research) will support research to investigate the construct validity of smartwatch-derived metrics against conventional neuropsychological measures for detecting cognitive change and differentiating individuals across the Alzheimer's disease (AD) continuum. The study will recruit a diverse sample of 90 participants aged 55 and older with either healthy cognition or mild cognitive impairment from the...
- This $6,448,430 Project Grant award from the National Institute on Aging (NIA) under the Aging Research federal grant program (CFDA 93.866) is focused on identifying multi-scale mechanisms for the age-related increase in the metabolic cost of walking. The central hypothesis is that older adults select slower gait speeds to prioritize stability over economy, and these "safer", proximally-biased gaits combine with declines in neuromuscular efficiency to elevate the metabolic cost of...
- This Project Grant award of $152,237 from the National Institute on Aging (NIA), under the Aging Research federal grant program (CFDA 93.866), aims to investigate the neuromuscular adaptation to exercise in Alzheimer's disease (AD) during the early stages. The study will be conducted by Virginia Polytechnic Institute & State University (Virginia Tech) and seeks to define the adaptive neuromuscular mechanisms in relation to established neuropathological changes over the continuum of AD-like...
- The University of Massachusetts received a $673,012 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) on August 15, 2025 to conduct research on the "Neuromechanical Bases for the Increased Energy Cost of Walking in Aging." The project aims to determine how age-related changes in gait strategy and deficits in key locomotory muscle groups contribute to the increased energy cost of walking in older adults. The research will address missing knowledge...
- The National Institute on Aging (CFDA 93.866 Aging Research) awarded a $730,089 project grant to The Washington University to conduct the LIFE-SPACE, ISOLATION, AND FUNCTIONAL EXPOSOME STUDY IN PRECLINICAL ALZHEIMER'S DISEASE AND COGNITIVE ENVIRONMENTS (LIFESPACE) project. The overarching goal of this 5-year study is to examine and improve the validity and generalizability of digital signals collected from everyday activities in identifying biological markers of Alzheimer's disease using a...
- This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $129,659 to The Johns Hopkins University to conduct a longitudinal study examining the relationship between physical activity, sleep, and neuroimaging biomarkers as potential correlates of cognitive resilience in older adults, including those with Alzheimer's disease pathology. The study aims to determine if physical activity and sleep are factors associated with cognitive resilience to...
- This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $204,806 to the University of Colorado-Denver to adapt and pilot test the TIME2CONNECT intervention, an evidence-based creative storytelling program, for older adults with mild cognitive impairment (MCI) or mild Alzheimer's disease and related dementias (ADRD) in the primary care setting. The project aims to: 1) assess psychosocial mechanisms of loneliness in this population, 2) adapt the...
LOCOMOTION ADAPTATION DEFICITS IN OLDER ADULTS WITH MILD COGNITIVE IMPAIRMENT AND ALZHEIMERS DISEASE - PROJECT ABSTRACT COMMUNITY WALKING FUNCTION REQUIRES COMPLEX MOTOR COORDINATION, SENSORY FEEDBACK, DYNAMIC BALANCE, ADAPTATION TO CHANGING ENVIRONMENTAL STIMULI, WHILE ALSO ATTENDING TO TASKS SUCH AS CROSSING A STREET OR TALKING OVER THE PHONE. UNFORTUNATELY, COGNITIVE DYSFUNCTION, THE HALLMARK OF MILD COGNITIVE IMPAIRMENTS (MCI) AND ALZHEIMER'S DISEASE (AD), DIRECTLY IMPACTS THE COGNITIVE-MOTOR NEURAL RESOURCES AVAILABLE TO CARRY OUT SUCH ACTIVITIES OF DAILY LIVING. THE RIGOR OF PREVIOUS RESEARCH SHOWS THAT COMPARED TO HEALTHY OLDER ADULTS (HOA), PEOPLE WITH MCI AND AD WALK SLOWER, FALL MORE, AND HAVE DEFICITS IN GAIT PERFORMANCE. NOTABLY, GAIT DISTURBANCES AND CHANGES IN GAIT VARIABILITY OFTEN PRECEDE COGNITIVE DECLINE. THUS, OUR OVERALL GOAL IS TO UNDERSTAND THE EFFECTS OF MCI AND AD ON GAIT FUNCTION AND LOCOMOTOR FLEXIBILITY, AND THE INTER-RELATIONSHIPS WITH COGNITIVE IMPAIRMENTS. LOCOMOTOR ADAPTATION IS A FUNDAMENTALLY IMPORTANT PROCESS THAT ENABLES HUMANS TO FLEXIBILITY RESPOND TO ENVIRONMENTAL DEMANDS, ENABLING NORMAL COMMUNITY WALKING FUNCTION. SPLIT-BELT WALKING IS A STANDARDIZED, ROBUST, WELL STUDIED PARADIGM FOR QUANTIFYING CAPACITY FOR LOCOMOTOR ADAPTATION, WITH POTENTIAL IMPLICATIONS FOR WALKING FUNCTION AND FALL PREVENTION. DESPITE A LARGE BODY OF LITERATURE ON SPLIT-BELT ADAPTATION IN INDIVIDUALS OF MULTIPLE AGES AND NEURO-PATHOLOGIES, SURPRISINGLY, SPLIT-BELT ADAPTATION HAS NOT BEEN ASSESSED IN MCI AND AD. A PREVIOUS STUDY SHOWED REDUCTION IN THE RATE OF SPLIT-BELT ADAPTATION WHEN ABLE-BODIED PARTICIPANTS WERE DISTRACTED BY A COGNITIVE TASK, SUGGESTING THAT ADAPTATION PROCESSES INTERACT WITH COGNITIVE FUNCTIONS. ANOTHER STUDY SHOWED MULTIPLE SESSIONS OF SPLIT-BELT WALKING IMPROVED MOBILITY OUTCOMES POST- STROKE, SUGGESTING ITS POTENTIAL AS AN EXERCISE INTERVENTION. HOWEVER, THERE IS A KNOWLEDGE GAP REGARDING IF AND HOW SPLIT-BELT ADAPTATION RELATES TO COGNITIVE DEFICITS AND WALKING FUNCTION IN INDIVIDUALS WITH MCI AND AD. THE CURRENT R21 WILL BUILD UPON MPI KESAR AND NOCERA'S NEW PUBLISHED STUDY THAT PROVIDES THE FIRST PRELIMINARY EVIDENCE THAT SPLIT-BELT ADAPTATION IS SIGNIFICANTLY IMPAIRED IN PEOPLE WITH MCI AND AD COMPARED TO HOA. OUR PREMISE IS THAT IN PEOPLE WITH MCI AND AD, REDUCED CAPACITY FOR LOCOMOTOR ADAPTATION IS A FUNDAMENTAL BUT POORLY UNDERSTOOD MECHANISM THAT CAN BE A SENSITIVE BIOMARKER OF COGNITIVE-MOTOR IMPAIRMENTS, AND AN IMPORTANT THERAPEUTIC TARGET FOR EXERCISE-BASED INTERVENTIONS. HERE, WE PROPOSE THE FIRST COMPARISON OF SPLIT- BELT ADAPTATION, IN CONJUNCTION WITH COMPREHENSIVE ASSESSMENTS OF GAIT AND COGNITIVE FUNCTION, IN MCI, AD, AND HOA. WE PROPOSE A UNIQUE COMBINATION OF CROSS-SECTIONAL BETWEEN-GROUP COMPARISONS (AIM 1) AND REPEATED- MEASURES LONGITUDINAL TIME-POINT COMPARISONS OF DISEASE PROGRESSION (AIM 2). AIM 3 IS A PRELIMINARY FEASIBILITY STUDY TO GUIDE FUTURE CLINICAL TRIALS ON SPLIT-BELT AEROBIC WALKING EXERCISE INTERVENTIONS IN MCI AND AD. FURTHER, IN PARALLEL WITH LOCOMOTOR ADAPTATION (NOT PREVIOUSLY STUDIED), WE WILL ALSO EVALUATE WALKING FUNCTION (GAIT SPEED, GAIT ENDURANCE, MOBILITY OUTCOMES), GAIT PERFORMANCE (STEP LENGTH, GAIT VARIABILITY, STRIDE TIME), AND COGNITION IN THE SAME PARTICIPANT COHORT, GENERATING AN INNOVATIVE, RICH, MULTI-MODAL DATASET.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $0 | 12/10/25 | ||
| Not listed | $423.1k | 8/17/23 |